KDR and neoplasm: Some systemic agents may help sensitize the tumor to radiation, for example, sorafenib (through inhibition of radiation-induced VEGFR2 and its downstream extracellular-signal-regulated kinase (ERK) signaling pathway) induces deoxyribonucleic acid (DNA) damage, and block/delay DNA repair.